This is a synthetic peptide designed for use in combination with anti-BID Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
BID
Reaktivität: Human, Ratte, Maus
Wirt: Synthetic
BP
Applikationshinweise
Each Investigator should determine their own optimal working dilution for specific applications.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
Konzentration
1 mg/mL
Buffer
Final peptide concentration is 1 mg/mL in PBS.
Handhabung
Avoid repeated freeze-thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
Target
BID
(BH3 Interacting Domain Death Agonist (BID))
Hintergrund
This gene encodes a death agonist that heterodimerizes with either agonist BAX or antagonist BCL2. The encoded protein is a member of the BCL-2 family of cell death regulators. It is a mediator of mitochondrial damage induced by caspase-8 (CASP8), CASP8 cleaves this encoded protein, and the COOH-terminal part translocates to mitochondria where it triggers cytochrome c release. Multiple alternatively spliced transcript variants have been found, but the full-length nature of some variants has not been defined.
Alias Symbols: FP497, MGC15319, MGC42355
Protein Interaction Partner: BAX,BCL2,BCL2,BCL2A1,BCL2L1,BCL2L1,BCL2L1,BCL2L2,BNC1,PACS2,BCL2L1,BAK1,BAX,BCL2,BCL2A1,BCL2L1,BCL2L2,BID,CAPN1,CASP1,CASP10,CASP2,CASP3,CASP8,CSNK1A1,CSNK1E,CSNK2A1,CSNK2A2,CSNK2B,GZMB,MCL1,YWHAB,ARHGDIA,BCL2,BCL2A1,BCL2L1,BCL2L1,BCL2L2,BID,CAPN2,CASP10,